Published in Br J Surg on March 01, 2009
Advances and challenges in the management of acute colonic pseudo-obstruction (ogilvie syndrome). Clin Colon Rectal Surg (2012) 0.95
Endoscopy in the diagnosis and management of motility disorders. Dig Dis Sci (2011) 0.87
Neostigmine for acute colonic pseudo-obstruction: A meta-analysis. Ann Med Surg (Lond) (2014) 0.83
The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients. J Korean Surg Soc (2012) 0.78
Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility. Br J Pharmacol (2013) 0.78
The use of intravenous neostigmine in palliation of severe ileus. Case Rep Gastrointest Med (2013) 0.76
Mangiferin ameliorates the intestinal inflammatory response and the impaired gastrointestinal motility in mouse model of postoperative ileus. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.76
Fecal impaction: a systematic review of its medical complications. BMC Geriatr (2016) 0.75
An obstruction not to forget: Pseudo-obstruction (Ogilvie syndrome): Single center experience. Indian J Crit Care Med (2016) 0.75
Giant colonic volvulus due to colonic pseudo-obstruction. BMJ Case Rep (2015) 0.75
Neostigmine to relieve a suspected colonic pseudo-obstruction in a burn patient: a case-based review of the literature. Eplasty (2013) 0.75
Nonocclusive mesenteric ischemia associated with ogilvie syndrome. Case Rep Surg (2014) 0.75
Acute Colonic Pseudo-Obstruction with Feeding Intolerance in Critically Ill Patients: A Study according to Gut Wall Analysis. Gastroenterol Res Pract (2017) 0.75
Pelvic surgeons be aware: Ogilvie's syndrome (a case report). Int Urogynecol J (2012) 0.75
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut (2009) 2.48
Rectus sheath haematoma associated with low molecular weight heparin: a case series. Ann R Coll Surg Engl (2007) 1.61
Use of antibiotic prophylaxis in elective inguinal hernia repair in adults in London and south-east England: a cross-sectional survey. Hernia (2013) 1.50
The effects of age and childbirth on anal sphincter function and morphology in 999 symptomatic female patients with colorectal dysfunction. Dis Colon Rectum (2012) 1.46
Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study. Aliment Pharmacol Ther (2011) 1.44
Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg (2015) 1.40
Creation of a treatment protocol for nurse-led management of anal fissure. Colorectal Dis (2003) 1.39
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil (2001) 1.24
Complications of intestinal stomas. Br J Surg (2010) 1.16
Normal values for high-resolution anorectal manometry: a time for consensus and collaboration. Neurogastroenterol Motil (2014) 1.12
Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil (2009) 1.07
Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine. J Pediatr Surg (2001) 0.93
Clinical and psychosocial functioning in adolescents and young adults with anorectal malformations and chronic idiopathic constipation. Br J Surg (2013) 0.92
'Efficient' timely evacuation of intracranial haematoma--the effect of transport direct to a specialist centre. Injury (1996) 0.91
Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin Exp Immunol (2010) 0.91
Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br J Surg (2013) 0.89
A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil (2014) 0.88
Psychophysiological responses to visceral and somatic pain in functional chest pain identify clinically relevant pain clusters. Neurogastroenterol Motil (2013) 0.85
Evacuation proctography: a reappraisal of normal variability. Colorectal Dis (2014) 0.85
Use of the surgical Apgar score to guide postoperative care. Ann R Coll Surg Engl (2014) 0.85
Traditional measures of normal anal sphincter function using high-resolution anorectal manometry (HRAM) in 115 healthy volunteers. Neurogastroenterol Motil (2014) 0.85
Systematic review of tibial nerve stimulation to treat faecal incontinence. Br J Surg (2014) 0.85
Scintigraphic assessment of colonic transit in women with slow-transit constipation arising de novo and following pelvic surgery or childbirth. Br J Surg (2001) 0.84
Decreased tyrosine kinase C expression may reflect developmental abnormalities in Hirschsprung's disease and idiopathic slow-transit constipation. Br J Surg (2001) 0.83
Short-term outcome following percutaneous tibial nerve stimulation for faecal incontinence: a single-centre prospective study. Colorectal Dis (2012) 0.82
Effects of age and gender on three-dimensional endoanal ultrasonography measurements: development of normal ranges. Tech Coloproctol (2008) 0.81
Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg (2002) 0.81
Translational neuropharmacology: the use of human isolated gastrointestinal tissues. Br J Pharmacol (2013) 0.81
Automated quantitative analysis of nocturnal jejunal motor activity identifies abnormalities in individuals and subgroups of patients with slow transit constipation. Am J Gastroenterol (2003) 0.81
Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. Br J Surg (2015) 0.81
The nocturnal jejunal migrating motor complex: defining normal ranges by study of 51 healthy adult volunteers and meta-analysis. Neurogastroenterol Motil (2006) 0.80
Novel concepts in the diagnosis, pathophysiology and management of idiopathic megabowel. Colorectal Dis (2008) 0.79
The influence of sacral nerve stimulation on anorectal dysfunction. Colorectal Dis (2011) 0.79
Normalization of substance P levels in rectal mucosa of patients with faecal incontinence treated successfully by sacral nerve stimulation. Br J Surg (2008) 0.78
Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility. Br J Pharmacol (2013) 0.78
Discordant practice and limited histopathological assessment in gastrointestinal neuromuscular disease. Gut (2009) 0.78
Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int (1999) 0.77
The Snug Seton: short and medium term results of slow fistulotomy for idiopathic anal fistulae. Colorectal Dis (2006) 0.77
Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: a case-control study. Neurogastroenterol Motil (2015) 0.76
Hirschsprung's disease: a more generalised neuropathy? J Pediatr Surg (2001) 0.76
Exaggerated rectal adaptation - another cause of outlet obstruction. Colorectal Dis (2001) 0.76
Chronic intestinal pseudo-obstruction related to viral infections. Transplant Proc (2010) 0.76
Idiopathic slow transit constipation and megacolon are not associated with neurturin mutations. Neurogastroenterol Motil (2002) 0.75
Effects of stimulation frequency and intensity in sacral neuromodulation on anorectal inputs to the somatosensory cortex in an experimental model. Br J Surg (2014) 0.75
Primary tracheal tuberculosis in an otherwise healthy 65-year-old Caucasian woman. J Laryngol Otol (1993) 0.75
Evidence of a role for GTP cyclohydrolase-1 in visceral pain. Neurogastroenterol Motil (2015) 0.75
Voltage-gated potassium channel (K(v) 1) autoantibodies in patients with chagasic gut dysmotility and distribution of K(v) 1 channels in human enteric neuromusculature (autoantibodies in GI dysmotility). Neurogastroenterol Motil (2012) 0.75